Sedating Antihistamines Interactions

Non-selective H1 receptor antagonists are contraindicated with tranylcypromine.

Source: NLP:tranylcypromine

Concomitant use increases risk of respiratory depression, profound sedation, coma, and death due to additive CNS depressant effects.

Source: NLP:buprenorphine hcl

Concurrent use may potentiate CNS adverse reactions and increase risk of intestinal obstruction and urinary retention. More frequent monitoring recommended.

Source: NLP:scopolamine

Sedative effects of sedating antihistamines may be potentiated when taken with doxepin.

Source: NLP:doxepin

Sedative effects of sedating antihistamines may be potentiated when taken with doxepin.

Source: NLP:doxepin hydrochloride

CNS depressants that may increase CNS depression when used with FYCOMPA. Patients should limit activity until experienced with concomitant use.

Source: NLP:perampanel

Concurrent use may potentiate CNS adverse reactions including drowsiness, dizziness, or disorientation due to anticholinergic properties.

Source: NLP:scolopamine transdermal system